Diamond Light Source

Activities: Research & Development

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    CDMO insights: development and manufacture of a highly potent OSD product In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t...
  3. Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and...
  4. Accumulus Synergy teams up with CEPI to expedite the vaccine regulatory approval process Through Accumulus' cloud-based technology, the two organisations aim to accelerate the accessibility of data for the regulatory approval process of vaccines globally, enhancing...
  5. Manufacturing Chemist Stand Side with Enzene Biosciences at CPHI Milan 2024 We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

Structural biology accelerates structure-based drug design against COVID-19

A new paper in <i>Nature Communications</i> outlines how an international research team has identified potential ways to rapidly design improved and more potent compounds in the fight against COVID-19
Ingredients

Transatlantic partnership to screen 15,000 drugs for COVID-19 treatments

Exscientia has announced a joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps Research 
Research & Development

Thermo Fisher Scientific and Diamond Light Source create step change for life sciences

UK set to be global leader in providing large-scale industrial access to Cryo-EM for drug discovery following the collaboration
Research & Development

New synthetic polio vaccine candidate visualised at the atomic scale at Diamond

Plants have been used to produce a new vaccine against poliovirus in what is hoped to be a major step towards global eradication of the disease
Research & Development

New UK facility to accelerate drug discovery

Diamond’s on-site fragment screening facility is a major boost for structural biologists
Research & Development

Scientists use new technology to develop a path for a novel synthetic polio vaccine

Includes a combination of X-ray crystallography and electron cryo-microscopy
Regulatory

Diamond shines light on basic building blocks of life

Crystal laboratory allows viruses to be analysed at atomic and molecular level
Subscribe now